SCHEMBL686996

SCHEMBL686996

CCOc1cccc([C@H](CC(=O)O)NC(=O)Nc2c(O)c(C)cn(Cc3c(Cl)cccc3OC(C)C)c2=O)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX3 P56373 3/20 0.35
FFAR1 O14842 3/20 0.35
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 2/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HTT P42858 1/20 0.34
RECQL P46063 1/20 0.34
GPR35 Q9HC97 1/20 0.34
CTSA P10619 1/20 0.33
KMT2A Q03164 1/20 0.33
ITGB1 P05556 2/20 0.33
ITGA4 P13612 2/20 0.33
PTGER3 P43115 1/20 0.33
PPARG P37231 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL687119 0.96 SMN1; SMN2 (0.36) P2RX3FFAR1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL686989 0.95 SMN1; SMN2 (0.38) FFAR1ALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL688501 0.94 SMN1; SMN2 (0.40) FFAR1ALDH1A1SMN1; SMN2KDM4ELMNA
SCHEMBL688946 0.93 SMN1; SMN2 (0.34) FFAR1ALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL687688 0.92 SMN1; SMN2 (0.37) P2RX3FFAR1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL693144 0.92 KDM4E (0.37) FFAR1ALDH1A1SMN1; SMN2KDM4ECYP3A4
SCHEMBL688507 0.91 SMN1; SMN2 (0.38) FFAR1ALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL687802 0.90 CTSA (0.34) FFAR1ALDH1A1SMN1; SMN2KDM4ELMNA
SCHEMBL687907 0.89 SMN1; SMN2 (0.38) FFAR1ALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL687970 0.89 SMN1; SMN2 (0.41) FFAR1ALDH1A1SMN1; SMN2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed